Erratum: Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery (Canadian Journal of Cardiology (2017) 33(1) (17–32)(S0828282X16309801)(10.1016/j.cjca.2016.09.008));Canadian Cardiovascular Society Guidelines on Perioperative Cardiac Risk Assessment and Management for Patients Who Undergo Noncardiac Surgery

Canadian Journal of Cardiology

Volumn 33, Issue 1, 2017, Pages 17-32

  Duceppe, Emmanuelle ^a,b,c   Parlow, Joel ^d   MacDonald, Paul ^e   Lyons, Kristin ^f   McMullen, Michael ^d   Srinathan, Sadeesh ^g   Graham, Michelle ^h   Tandon, Vikas ^b   Styles, Kim ⁱ   Bessissow, Amal ^j   Sessler, Daniel I ^k   Bryson, Gregory ^l,m   Devereaux, P J ^b,c  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c HAMILTON HEALTH SCIENCES   (Canada)

^d QUEEN S UNIVERSITY   (Canada)

^e Cape Breton Regional Hospital   (Canada)

^f UNIVERSITY OF CALGARY   (Canada)

^g UNIVERSITY OF MANITOBA   (Canada)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ DALHOUSIE UNIVERSITY   (Canada)

^j MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^k LERNER RESEARCH INSTITUTE   (United States)

^l UNIVERSITY OF OTTAWA   (Canada)

^m OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN;

ADULT; AGED; ARTICLE; CANADIAN; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR DISEASE; CARDIOVASCULAR DISEASE ASSESSMENT; CARDIOVASCULAR RISK; CAROTID ENDARTERECTOMY; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ANGIOGRAPHY; CORONARY ARTERY RECANALIZATION; CORONARY STENT; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FUNCTIONAL STATUS; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE INJURY; HEART SCINTISCANNING; HUMAN; LONG TERM CARE; MEDICAL SOCIETY; NONCARDIAC SURGERY; PATIENT MONITORING; PERIOPERATIVE PERIOD; PHARMACOLOGIC STRESS TESTING; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PROTEIN BLOOD LEVEL; PULMONARY ARTERY CATHETER; RESTING ECHOCARDIOGRAPHY; REVISED CARDIAC RISK INDEX SCORE; RISK ASSESSMENT; SCORING SYSTEM; SELF REPORT; SMOKING CESSATION; STRESS ECHOCARDIOGRAPHY; SURGICAL APPROACH; SURGICAL PATIENT; SURGICAL RISK; TELEMETRY; CANADA; CARDIOLOGY; CARDIOVASCULAR DISEASES; DISEASE MANAGEMENT; SURGERY;

CANADA; CARDIOLOGY; CARDIOVASCULAR DISEASES; DISEASE MANAGEMENT; HUMANS; PERIOPERATIVE PERIOD; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SOCIETIES, MEDICAL; SURGICAL PROCEDURES, OPERATIVE;

EID: 85006630775     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2017.04.002     Document Type: Erratum

References (88)

1. 1 Weiser, T.G., Regenbogen, S.E., Thompson, K.D., et al. An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet 372 (2008), 139–144.
2. 2 Botto, F., Alonso-Coello, P., Chan, M.T., et al. Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes. Anesthesiology 120 (2014), 564–578.
3. 3 Siddiqui, N.F., Coca, S.G., Devereaux, P.J., et al. Secular trends in acute dialysis after elective major surgery–1995 to 2009. CMAJ 184 (2012), 1237–1245.
4. 4 van Waes, J.A., Nathoe, H.M., de Graaff, J.C., et al. Myocardial injury after noncardiac surgery and its association with short-term mortality. Circulation 127 (2013), 2264–2271.
5. 5 Udeh, B.L., Dalton, J.E., Hata, J.S., Udeh, C.I., Sessler, D.I., Economic trends from 2003 to 2010 for perioperative myocardial infarction: a retrospective, cohort study. Anesthesiology 121 (2014), 36–45.
6. 6 Levy, M., Heels-Ansdell, D., Hiralal, R., et al. Prognostic value of troponin and creatine kinase muscle and brain isoenzyme measurement after noncardiac surgery: a systematic review and meta-analysis. Anesthesiology 114 (2011), 796–806.
7. 7 Fleisher, L.A., Fleischmann, K.E., Auerbach, A.D., et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130 (2014), e278–e333.
8. 8 Kristensen, S.D., Knuuti, J., Saraste, A., et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 35 (2014), 2383–2431.
9. 9 Guyatt, G.H., Oxman, A.D., Vist, G.E., et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 336 (2008), 924–926.
10. 10 Erasmus MC, Follow-up Investigation Committee. Report on the 2012 follow-up investigation of possible breaches of academic integrity. September 30, 2012.
11. 11 Guyatt, G.H., Cook, D.J., Jaeschke, R., Pauker, S.G., Schunemann, H.J., Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133 (2008), 123S–131S.
12. 12 Guyatt, G.H., Schunemann, H.J., Djulbegovic, B., Akl, E.A., Guideline panels should not GRADE good practice statements. J Clin Epidemiol 68 (2015), 597–600.
13. 13 Lee, T.H., Marcantonio, E.R., Mangione, C.M., et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 100 (1999), 1043–1049.
14. 14 Sabate, S., Mases, A., Guilera, N., et al. Incidence and predictors of major perioperative adverse cardiac and cerebrovascular events in non-cardiac surgery. Br J Anaesth 107 (2011), 879–890.
15. 15 Gupta, P.K., Gupta, H., Sundaram, A., et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery. Circulation 124 (2011), 381–387.
16. 16 Agarwal, S., Rajamanickam, A., Bajaj, N.S., et al. Impact of aortic stenosis on postoperative outcomes after noncardiac surgeries. Circ Cardiovasc Qual Outcomes 6 (2013), 193–200.
17. 17 Taher, T., Khan, N.A., Devereaux, P.J., et al. Assessment and reporting of perioperative cardiac risk by Canadian general internists: art or science?. J Gen Intern Med 17 (2002), 933–936.
18. 18 Trevena, L.J., Davey, H.M., Barratt, A., Butow, P., Caldwell, P., A systematic review on communicating with patients about evidence. J Eval Clin Pract 12 (2006), 13–23.
19. 19 Bilimoria, K.Y., Liu, Y., Paruch, J.L., et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg 217 (2013), 833–842.
20. 20 Ford, M.K., Beattie, W.S., Wijeysundera, D.N., Systematic review: prediction of perioperative cardiac complications and mortality by the revised cardiac risk index. Ann Intern Med 152 (2010), 26–35.
21. 21 Devereaux, P.J., Bradley, D., Chan, M.T., et al. An international prospective cohort study evaluating major vascular complications among patients undergoing noncardiac surgery: the VISION Pilot Study. Open Med 5 (2011), e193–e200.
22. 22 Sheth, T., Chan, M., Butler, C., et al. Prognostic capabilities of coronary computed tomographic angiography before non-cardiac surgery: prospective cohort study. BMJ, 350, 2015, h1907.
23. 23 Ausset, S., Auroy, Y., Lambert, E., et al. Cardiac troponin I release after hip surgery correlates with poor long-term cardiac outcome. Eur J Anaesthesiol 25 (2008), 158–164.
24. 24 Cuthbertson, B.H., Amiri, A.R., Croal, B.L., et al. Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. Br J Anaesth 99 (2007), 170–176.
25. 25 Rajagopalan, S., Croal, B.L., Bachoo, P., et al. N-terminal pro B-type natriuretic peptide is an independent predictor of postoperative myocardial injury in patients undergoing major vascular surgery. J Vasc Surg 48 (2008), 912–917.
26. 26 Devereaux, P.J., Goldman, L., Cook, D.J., et al. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. CMAJ 173 (2005), 627–634.
27. 27 Devereaux, P.J., Xavier, D., Pogue, J., et al. Characteristics and short-term prognosis of perioperative myocardial infarction in patients undergoing noncardiac surgery: a cohort study. Ann Intern Med 154 (2011), 523–528.
28. 28 Fleisher, L.A., Fleischmann, K.E., Auerbach, A.D., et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130 (2014), 2215–2245.
29. 29 Reilly, D.F., McNeely, M.J., Doerner, D., et al. Self-reported exercise tolerance and the risk of serious perioperative complications. Arch Intern Med 159 (1999), 2185–2192.
30. 30 Wiklund, R.A., Stein, H.D., Rosenbaum, S.H., Activities of daily living and cardiovascular complications following elective, noncardiac surgery. Yale J Biol Med 74 (2001), 75–87.
31. 31 Wijeysundera, D.N., Pearse, R.M., Shulman, M.A., et al. Measurement of Exercise Tolerance before Surgery (METS) study: a protocol for an international multicentre prospective cohort study of cardiopulmonary exercise testing prior to major non-cardiac surgery. BMJ Open, 6, 2016, e010359.
32. 32 Struthers, A., Lang, C., The potential to improve primary prevention in the future by using BNP/N-BNP as an indicator of silent ‘pancardiac’ target organ damage: BNP/N-BNP could become for the heart what microalbuminuria is for the kidney. Eur Heart J 28 (2007), 1678–1682.
33. 33 Luchner, A., Stevens, T.L., Borgeson, D.D., et al. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure. Am J Physiol 274 (1998), H1684–H1689.
34. 34 Clerico, A., Giannoni, A., Vittorini, S., Passino, C., Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones. Am J Physiol Heart Circ Physiol 301 (2011), H12–H20.
35. 35 Rodseth, R.N., Biccard, B.M., Le Manach, Y., et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol 63 (2014), 170–180.
36. 36 Karthikeyan, G., Moncur, R.A., Levine, O., et al. Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studies. J Am Coll Cardiol 54 (2009), 1599–1606.
37. 37 Ryding, A.D., Kumar, S., Worthington, A.M., Burgess, D., Prognostic value of brain natriuretic peptide in noncardiac surgery: a meta-analysis. Anesthesiology 111 (2009), 311–319.
38. 38 Rodseth, R.N., Padayachee, L., Biccard, B.M., A meta-analysis of the utility of pre-operative brain natriuretic peptide in predicting early and intermediate-term mortality and major adverse cardiac events in vascular surgical patients. Anaesthesia 63 (2008), 1226–1233.
39. 39 Young, Y.R., Sheu, B.F., Li, W.C., et al. Predictive value of plasma brain natriuretic peptide for postoperative cardiac complications; a systemic review and meta-analysis. J Crit Care 29 (2014), 696.e1–696.e10.
40. 40 Halm, E.A., Browner, W.S., Tubau, J.F., Tateo, I.M., Mangano, D.T., Echocardiography for assessing cardiac risk in patients having noncardiac surgery. Study of Perioperative Ischemia Research Group. Ann Intern Med 125 (1996), 433–441.
41. 41 Rohde, L.E., Polanczyk, C.A., Goldman, L., et al. Usefulness of transthoracic echocardiography as a tool for risk stratification of patients undergoing major noncardiac surgery. Am J Cardiol 87 (2001), 505–509.
42. 42 Park, S.J., Choi, J.H., Cho, S.J., et al. Comparison of transthoracic echocardiography with N-terminal pro-brain natriuretic peptide as a tool for risk stratification of patients undergoing major noncardiac surgery. Korean Circ J 41 (2011), 505–511.
43. 43 Beattie, W.S., Abdelnaem, E., Wijeysundera, D.N., Buckley, D.N., A meta-analytic comparison of preoperative stress echocardiography and nuclear scintigraphy imaging. Anesth Analg 102 (2006), 8–16.
44. 44 Etchells, E., Meade, M., Tomlinson, G., Cook, D., Semiquantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: a meta-analysis. J Vasc Surg 36 (2002), 534–540.
45. 45 Kaaja, R., Sell, H., Erkola, O., Harjula, A., Predictive value of manual ECG-monitored exercise test before abdominal aortic or peripheral vascular surgery. Angiology 44 (1993), 11–15.
46. 46 McPhail, N., Calvin, J.E., Shariatmadar, A., Barber, G.G., Scobie, T.K., The use of preoperative exercise testing to predict cardiac complications after arterial reconstruction. J Vasc Surg 7 (1988), 60–68.
47. 47 Carliner, N.H., Fisher, M.L., Plotnick, G.D., et al. Routine preoperative exercise testing in patients undergoing major noncardiac surgery. Am J Cardiol 56 (1985), 51–58.
48. 48 Sgura, F.A., Kopecky, S.L., Grill, J.P., Gibbons, R.J., Supine exercise capacity identifies patients at low risk for perioperative cardiovascular events and predicts long-term survival. Am J Med 108 (2000), 334–336.
49. 49 Colson, M., Baglin, J., Bolsin, S., Grocott, M.P., Cardiopulmonary exercise testing predicts 5 yr survival after major surgery. Br J Anaesth 109 (2012), 735–741.
50. 50 Grant, S.W., Hickey, G.L., Wisely, N.A., et al. Cardiopulmonary exercise testing and survival after elective abdominal aortic aneurysm repairdagger. Br J Anaesth 114 (2015), 430–436.
51. 51 Lai, C.W., Minto, G., Challand, C.P., et al. Patients’ inability to perform a preoperative cardiopulmonary exercise test or demonstrate an anaerobic threshold is associated with inferior outcomes after major colorectal surgery. Br J Anaesth 111 (2013), 607–611.
52. 52 Hartley, R.A., Pichel, A.C., Grant, S.W., et al. Preoperative cardiopulmonary exercise testing and risk of early mortality following abdominal aortic aneurysm repair. Br J Surg 99 (2012), 1539–1546.
53. 53 Carlisle, J., Swart, M., Mid-term survival after abdominal aortic aneurysm surgery predicted by cardiopulmonary exercise testing. Br J Surg 94 (2007), 966–969.
54. 54 Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trial. Lancet 355 (2000), 1295–1302.
55. 55 Devereaux, P.J., Mrkobrada, M., Sessler, D.I., et al. Aspirin in patients undergoing noncardiac surgery. N Engl J Med 370 (2014), 1494–1503.
56. 56 Devereaux, P.J., POISE-2 Investigators. Rationale and design of the PeriOperative ISchemic Evaluation-2 (POISE-2) trial: an international 2 x 2 factorial randomized controlled trial of acetyl-salicylic acid vs. placebo and clonidine vs. placebo in patients undergoing noncardiac surgery. Am Heart J 167 (2014), 804–809.e4.
57. 57 Wijeysundera, D.N., Duncan, D., Nkonde-Price, C., et al. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 130 (2014), 2246–2264.
58. 58 Devereaux, P.J., Yang, H., Yusuf, S., et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial. Lancet 371 (2008), 1839–1847.
59. 59 Fleisher, L.A., Poldermans, D., Perioperative beta blockade: where do we go from here?. Lancet 371 (2008), 1813–1814.
60. 60 Devereaux, P.J., Sessler, D.I., Leslie, K., et al. Clonidine in patients undergoing noncardiac surgery. N Engl J Med 370 (2014), 1504–1513.
61. 61 Wallace, A.W., Au, S., Cason, B.A., Association of the pattern of use of perioperative beta-blockade and postoperative mortality. Anesthesiology 113 (2010), 794–805.
62. 62 Wijeysundera, D.N., Bender, J.S., Beattie, W.S., Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. Cochrane Database Syst Rev, 2009, CD004126.
63. 63 Wijeysundera, D.N., Beattie, W.S., Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg 97 (2003), 634–641.
64. 64 Coriat, P., Richer, C., Douraki, T., et al. Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction. Anesthesiology 81 (1994), 299–307.
65. 65 Bertrand, M., Godet, G., Meersschaert, K., et al. Should the angiotensin II antagonists be discontinued before surgery?. Anesth Analg 92 (2001), 26–30.
66. 66 Schirmer, U., Schurmann, W., Preoperative administration of angiotensin-converting enzyme inhibitors [in German]. Anaesthesist 56 (2007), 557–561.
67. 67 Sanders, R.D., Nicholson, A., Lewis, S.R., Smith, A.F., Alderson, P., Perioperative statin therapy for improving outcomes during and after noncardiac vascular surgery. Cochrane Database Syst Rev, 2013, CD009971.
68. 68 Xia, J., Qu, Y., Yin, C., Xu, D., Preoperative rosuvastatin protects patients with coronary artery disease undergoing noncardiac surgery. Cardiology 131 (2015), 30–37.
69. 69 Illuminati, G., Ricco, J.B., Greco, C., et al. Systematic preoperative coronary angiography and stenting improves postoperative results of carotid endarterectomy in patients with asymptomatic coronary artery disease: a randomised controlled trial. Eur J Vasc Endovasc Surg 39 (2010), 139–145.
70. 70 Illuminati, G., Schneider, F., Greco, C., et al. Long-term results of a randomized controlled trial analyzing the role of systematic pre-operative coronary angiography before elective carotid endarterectomy in patients with asymptomatic coronary artery disease. Eur J Vasc Endovasc Surg 49 (2015), 366–374.
71. 71 McFalls, E.O., Ward, H.B., Moritz, T.E., et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 351 (2004), 2795–2804.
72. 72 Hawn, M.T., Graham, L.A., Richman, J.S., et al. Risk of major adverse cardiac events following noncardiac surgery in patients with coronary stents. JAMA 310 (2013), 1462–1472.
73. 73 Wijeysundera, D.N., Wijeysundera, H.C., Yun, L., et al. Risk of elective major noncardiac surgery after coronary stent insertion: a population-based study. Circulation 126 (2012), 1355–1362.
74. 74 Thomsen, T., Villebro, N., Moller, A.M., Interventions for preoperative smoking cessation. Cochrane Database Syst Rev, 2014, CD002294.
75. 75 Devereaux, P.J., Chan, M.T., Alonso-Coello, P., et al. Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery. JAMA 307 (2012), 2295–2304.
76. 76 Beattie, W.S., Karkouti, K., Tait, G., et al. Use of clinically based troponin underestimates the cardiac injury in non-cardiac surgery: a single-centre cohort study in 51,701 consecutive patients. Can J Anaesth 59 (2012), 1013–1022.
77. 77 Torborg, A., Ryan, L., Kantor, G., Biccard, B.M., The pharmacoeconomics of routine postoperative troponin surveillance to prevent and treat myocardial infarction after non-cardiac surgery. S Afr Med J 104 (2014), 619–623.
78. 78 Mangano, D.T., Browner, W.S., Hollenberg, M., et al. Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. The Study of Perioperative Ischemia Research Group. N Engl J Med 323 (1990), 1781–1788.
79. 79 Landesberg, G., Luria, M.H., Cotev, S., et al. Importance of long-duration postoperative ST-segment depression in cardiac morbidity after vascular surgery. Lancet 341 (1993), 715–719.
80. 80 Rinfret, S., Goldman, L., Polanczyk, C.A., Cook, E.F., Lee, T.H., Value of immediate postoperative electrocardiogram to update risk stratification after major noncardiac surgery. Am J Cardiol 94 (2004), 1017–1022.
81. 81 Bottiger, B.W., Motsch, J., Teschendorf, P., et al. Postoperative 12-lead ECG predicts peri-operative myocardial ischaemia associated with myocardial cell damage. Anaesthesia 59 (2004), 1083–1090.
82. 82 Landesberg, G., Mosseri, M., Zahger, D., et al. Myocardial infarction after vascular surgery: the role of prolonged stress-induced, ST depression-type ischemia. J Am Coll Cardiol 37 (2001), 1839–1845.
83. 83 Raby, K.E., Barry, J., Creager, M.A., et al. Detection and significance of intraoperative and postoperative myocardial ischemia in peripheral vascular surgery. JAMA 268 (1992), 222–227.
84. 84 Landesberg, G., Shatz, V., Akopnik, I., et al. Association of cardiac troponin, CK-MB, and postoperative myocardial ischemia with long-term survival after major vascular surgery. J Am Coll Cardiol 42 (2003), 1547–1554.
85. 85 Sandham, J.D., Hull, R.D., Brant, R.F., et al. A randomized, controlled trial of the use of pulmonary-artery catheters in high-risk surgical patients. N Engl J Med 348 (2003), 5–14.
86. 86 Shah, M.R., Hasselblad, V., Stevenson, L.W., et al. Impact of the pulmonary artery catheter in critically ill patients: meta-analysis of randomized clinical trials. JAMA 294 (2005), 1664–1670.
87. 87 Grigoryan, K.V., Javedan, H., Rudolph, J.L., Orthogeriatric care models and outcomes in hip fracture patients: a systematic review and meta-analysis. J Orthop Trauma 28 (2014), e49–e55.
88. 88 Foucrier, A., Rodseth, R., Aissaoui, M., et al. The long-term impact of early cardiovascular therapy intensification for postoperative troponin elevation after major vascular surgery. Anesth Analg 119 (2014), 1053–1063.